Eliem Therapeutics, Inc. (ELYM)
NASDAQ: ELYM · IEX Real-Time Price · USD
10.21
+1.56 (18.03%)
May 7, 2024, 3:59 PM EDT - Market closed
Eliem Therapeutics Analyst Ratings
Total Analysts
n/a
Consensus Rating
n/a
Price Target
n/a
Upside
n/a
Ratings History
Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
---|---|---|---|---|---|---|---|
HC Wainwright & Co. | HC Wainwright & Co. | Hold Reiterates $6 | Hold | Reiterates | $6 | -41.23% | Mar 8, 2023 |
HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy → Hold Downgrades n/a | Strong Buy → Hold | Downgrades | n/a | n/a | Feb 10, 2023 |
HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Initiates $6 | Strong Buy | Initiates | $6 | -41.23% | Oct 28, 2022 |
SVB Leerink | SVB Leerink | Buy Maintains $9 → $4 | Buy | Maintains | $9 → $4 | -60.82% | Aug 16, 2022 |
SVB Leerink | SVB Leerink | Buy Maintains $13 → $9 | Buy | Maintains | $13 → $9 | -11.85% | Jul 11, 2022 |
Guggenheim | Guggenheim | Strong Buy → Hold Downgrades n/a | Strong Buy → Hold | Downgrades | n/a | n/a | Apr 26, 2022 |
SVB Leerink | SVB Leerink | Buy Maintains $33 → $13 | Buy | Maintains | $33 → $13 | +27.33% | Apr 26, 2022 |
Guggenheim | Guggenheim | Strong Buy Initiates n/a | Strong Buy | Initiates | n/a | n/a | Sep 7, 2021 |
Stifel | Stifel | Strong Buy Initiates n/a | Strong Buy | Initiates | n/a | n/a | Sep 7, 2021 |
SVB Leerink | SVB Leerink | Buy Initiates n/a | Buy | Initiates | n/a | n/a | Sep 7, 2021 |